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Abstract Aggresomes and related inclusion bodies
appear to serve as storage depots for misfolded and
aggregated proteins within cells, which can potentially be
degraded by the autophagy pathway. A homogenous ﬂuo-
rescence-based assay was devised to detect aggregated
proteins inside aggresomes and inclusion bodies within an
authentic cellular context. The assay employs a novel red
ﬂuorescent molecular rotor dye, which is essentially
nonﬂuorescent until it binds to structural features associ-
ated with the aggregated protein cargo. Aggresomes and
related structures were generated within cultured cells
using various potent, cell permeable, proteasome inhibi-
tors: MG-132, lactacystin, epoxomicin and bortezomib,
and then selectively detected with the ﬂuorescent probe.
Employing the probe in combination with various ﬂuo-
rescein-labeled primary antibodies facilitated co-localiza-
tion of key components of the autophagy system (ubiquitin,
p62, and LC3) with aggregated protein cargo by ﬂuores-
cence microscopy. Furthermore, cytoplasmic aggregates
were highlighted in SK-N-SH human neuroblastoma cells
incubated with exogenously supplied amyloid beta peptide
1–42. SMER28, a small molecule modulator of autophagy
acting via an mTOR-independent mechanism, prevented
the accumulation of amyloid beta peptide within these
cells. The described assay allows assessment of the effects
of protein aggregation directly in cells, without resorting to
the use of non-physiological protein mutations or geneti-
cally engineered cell lines. With minor modiﬁcation, the
assay was also adapted to the analysis of frozen or
formalin-ﬁxed, parafﬁn-embedded tissue sections, with
demonstration of co-localization of aggregated cargo with
b-amyloid and tau proteins in brain tissue sections from
Alzheimer’s disease patients.
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Abbreviations
FBS Fetal bovine serum
EBSS Earle’s balanced salt solution
PBS Phosphate buffered saline
GFP Green ﬂuorescent protein
LC3 Microtubule associated proteins 1A/1B
light chain 3
DMSO Dimethyl sulfoxide
UPS Ubiquitin–proteasome system
HSR Heat shock response
UPR Unfolded protein response
ThT Thioﬂavin T
Introduction
Eukaryotic cells avoid accumulating extracellularly and
intracellularlly derived toxic protein aggregates using a
variety of homeostatic mechanisms, including the sup-
pression of their formation by the molecular chaperone
pathway and the degradation of any misfolded proteins by
the ubiquitin–proteasome system (UPS) [1]. However,
once protein aggregates have formed, they tend to become
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accumulate within various inclusion bodies. For example,
aggregated proteins may be concentrated by microtubule-
dependent retrograde transport to perinuclear sites of
aggregate deposition, referred to as aggresomes [2]. Typi-
cally, an aggresome forms in response to some cellular
stress, such as hyperthermia, viral infection or exposure to
reactive oxygen species. These inclusion bodies appear to
provide a cytoprotective function by sequestering the toxic,
aggregated proteins. Aggresomes and related inclusion
bodies that form when the UPS machinery is overwhelmed
with aggregated proteins, may serve as storage depots for
cargo awaiting degradation by autophagy. Certain cellular
inclusion bodies associated with human disease are thought
to arise from an aggresomal response, including neuroﬁ-
brillary tangles and amyloid plaques associated with neu-
rons in Alzheimer’s disease, Lewy bodies associated with
neurons in Parkinson’s disease, intranuclear and cytoplas-
mic inclusions associated with neurons in Huntington’s
disease, Mallory bodies associated with liver cells in
alcoholic liver disease, and hyaline inclusion bodies asso-
ciated with astrocytes in amyotrophic lateral sclerosis [3].
Aggresomes and related inclusion bodies can be moni-
tored by a variety of analytical methods including trans-
mission electron microscopy and the combination of
polyacrylamide gel electrophoresis and western blotting,
but these approaches are relatively low-throughput, time-
consuming, labor-intensive, and require much experience
for accurate interpretation [1, 4]. Certain wild-type or
mutant proteins fused with green ﬂuorescent protein (GFP)
can be transiently transfected into cultured cells in order to
create a model system that produces inclusion bodies that
may be analyzed by ﬂuorescence microscopy [5, 6]. While
certainly valuable for many investigations, this approach
does not allow analysis of native protein and peptide
aggregates within cells. Additionally, GFP is a relatively
large tag, which could potentially inﬂuence aggregation
kinetics [7].
We report upon a novel red ﬂuorescent molecular rotor
dye speciﬁcally devised to detect aggregated proteins and
peptides within aggresomes and related inclusion bodies.
The dye is essentially non-ﬂuorescent in solution, but
becomes brightly ﬂuorescent upon binding to the tertiary
structure of aggregated proteins. The assay has been vali-
dated using a range of conditions known to modulate the
UPS machinery and has been optimized for co-localization
studies with ﬂuorescently labeled antibodies, highlighting
interactions between aggregated protein and peptide cargo
with post-translational modiﬁcations and pathway proteins
implicated in aggresome formation and the autophagic
process in general, such as ubiquitin, p62 and, LC3. The
assay is compatible with ﬂow cytometry, allowing, for the
ﬁrst time, easy quantitation of denatured protein cargo
within cells. It is also suitable for highlighting neuroﬁ-
brillary plaques, composed of b-amyloid and tau protein, in
brain tissue thin sections from Alzheimer’s disease
patients.
Materials and Methods
Dyes and Reagents
ProteoStat
 Aggresome Detection Kit and anti-fade
mounting medium were from Enzo Life Sciences, Inc.
(Plymouth Meeting, PA). All components of ProteoStat

Aggresome Detection Kit were prepared according to the
manufacturer’s instructions. Thioﬂavin T, Nile Red, and
1,8-aminonaphthalene sulfonate (ANS) were from Sigma-
Aldrich Company (St. Louis, MO). SYPRO
 Orange dye
was from Life Technologies (Carlsbad, CA). 1 mM stock
solutions of the dyes were prepared in DMSO.
Fluorescence Enhancement upon Binding
to Aggregated Protein
Various ﬂuorescent dyes were evaluated with respect to the
increase in ﬂuorescence response in the presence of
aggregated protein relative to monomeric protein. Model
proteins included lysozyme, IgG, pyruvate kinase, and
trypsin (Sigma-Aldrich Company). Each protein was
denatured by incubation at elevated temperature. The assay
was performed using 5 lM of protein, either native or
aggregated, and a dye concentration of 5 lM. The protein
and dye were incubated together for 15 min at room tem-
perature. Fluorescence intensity values were collected on a
BioTek Synergy Mx ﬂuorescence microplate reader
(Winooski, VT). Fluorescence values were measured with
excitation and emission slit widths set to 9 nm, and at a
constant PMT voltage. Emission and excitation values
were customized for each dye shown in Fig. 1. The ﬂuo-
rescent response of each dye in the presence of native and
aggregated protein was determined as well as signal gen-
erated by free dye in buffer. The ratio of signal for
aggregated protein versus monomeric protein was deter-
mined after subtracting the no protein blank value.
Cell Culture
Human cervical adenocarcinoma epithelial cell line HeLa
and SK-N-SH neuroblastoma cell line were both obtained
from American Type Culture Collection (ATCC, Manas-
sas, VA). HeLa and SK-N-SH cells were routinely cultured
in Eagle’s Minimum Essential Medium (ATCC) with low
glucose, supplemented with 10% fetal bovine serum (FBS)
(ATCC) and 100 U/ml penicillin, 100 lg/ml streptomycin
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obtained from ATCC. Jurkat cells were grown in suspen-
sion in RPMI medium supplemented with 10% (v/v) FBS,
penicillin (100 U/ml), streptomycin (100 lg/ml), and glu-
tamine (200 mM). All cells were maintained in a saturated,
humidiﬁed atmosphere at 37C, 5% CO2, and 95% air.
Tissue Sections
Post-mortem brain tissue (cerebellum) from patients with
Alzheimer’s disease and human adult normal brain tissue
(cerebellum) were obtained from BioChain Institute, Inc
(Hayward, CA). All tissue samples were received from
certiﬁed tissue vendors who guarantee that they were col-
lected with informed consent from the donors and their
relatives, all samples were excised by licensed Medical
Doctors, all normal and diseased tissues were determined
by the donor’s clinical reports and all collections were
made with the relevant requirements for ethics committee/
IRB approvals. The frozen tissue sections were 5–10 lmi n
thickness, mounted on positively charged glass slides, and
ﬁxed with cold acetone by the manufacturer. The embed-
ded tissue sections were ﬁxed in formalin immediately
after excision, and embedded in parafﬁn. Tissue sections
were *5 lm in thickness, and mounted on positively
charged glass slides by the manufacturer.
Small Molecule Compound and Peptide Treatment
Proteasome inhibitors MG-132 (Enzo Life Sciences),
lactacystin (Enzo Life Sciences), bortezomib (Velcade
)
(Selleck Chemicals LLC, Houston, TX), and epoxomicin
(Enzo Life Sciences) were employed in the studies. The
histone deacetylase 6 inhibitor, N-hydroxy-7-[5-(4-tertbuto-
xycarbonylaminophenyl)-3-isoxazolecarboxamido] hepta-
mide (BML-281) was also obtained from Enzo Life Sci-
ences. The small molecule compounds were reconstituted
in DMSO at a concentration of 2 mM for preparation of a
stock solution and further diluted into culture medium to
the ﬁnal desired concentration prior to incubation with the
cells for 6–18 h. Negative control cells were treated with a
vehicle (DMSO, media or other solvent used to reconstitute
or dilute the inducer or inhibitor) for an equal length of
time under similar conditions.
Amyloid beta peptide 1–42 (21st Century Biochemicals,
Marlboro, MA) was added to the culture medium and
SK-N-SH cells were incubated overnight to induce aggre-
some formation. SMER28 (Enzo Life Sciences), an inducer
of autophagy was employed to block this accumulation.
Autophagy was induced by several other treatment
regimes as well. For amino acid starvation, cells were
washed four or ﬁve times in Earle’s Balanced Salt Solution
(EBSS) and incubated in EBSS for 1 h. Autophagy was also
induced by various compounds (chloroquine, verapamil,
rapamycin,PP242,lithium,trehalose,baﬁlomycinA1,hydro-
xychloroquine, loperamide, clonidine, and norclomipr-
amine). These small molecule compounds were obtained
from Sigma-Aldrich unless stated otherwise.
Antibodies
Antibodies were obtained from the following commercial
sources: ﬂuorescein-labeled p62 and LC3 reactive rabbit
polyclonal antibodies and ubiquitin-reactive mouse mono-
clonal antibody (clone EX-9) were obtained from Enzo
Life Sciences, Ltd. (Exeter, UK). These labeled conjugates
were produced by direct labeling of antibodies raised to
p62-derived, LC3-derived, and ubiquitin-derived peptides,
respectively. A mouse monoclonal antibody reactive with
human tau (clone tau-13) (Covance Inc, Emeryville, CA) is
able to stain brain tissue early in Alzheimer’s disease. It
was used in conjunction with Alexa Fluor
 488 dye-
labeled goat anti-mouse secondary antibody from Life
Technologies (Carlsbad, CA). Alexa Fluor
 488 dye-
labeled beta amyloid reactive mouse monoclonal antibody
(clone 6E10), which is speciﬁcally reactive to amino acid
residues 1–16 of the human b-amyloid peptide, was
obtained from Covance Inc.
Cell-Based Assay
Cells were grown on glass slides or polystyrene tissue
culture dishes until *80% conﬂuent. The cells were trea-
ted with various modulators or vehicle at various
Fig. 1 Fluorescence signal
enhancement of various
ﬂuorescent dyes in the presence
of aggregated IgG protein
relative to monomeric
counterpart. The graphs show
the ﬂuorescence intensity
increase obtained for aggregated
protein relative to monomeric
protein
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123concentrations and time intervals, as detailed in Table 1.
The cells were subsequently washed with PBS, and ﬁxed in
4% formaldehyde in PBS for 30 min at room temperature,
then permeabilized with 0.5% Triton X-100, 3 mM EDTA
in PBS on ice, for 30 min. The cells were washed with
PBS, and then ProteoStat
 dye (prepared according to kit
instructions) was added. The samples were incubated for
30 min at room temperature, protected from light. The cells
were washed with PBS, covered with glass coverslips and
observed using a ﬂuorescence microscope (Carl Zeiss
MicroImaging GmbH, Jena, Germany) equipped with a
Texas Red ﬁlter set. Images were acquired with a 639
objective lens (Carl Zeiss, Inc).
For antibody co-localization studies: cells were treated
overnight with 5 lM MG-132, then ﬁxed and permeabilized
using the above protocol. Then, the cells were incubated in
PBScontaining3%bovineserumalbumin(blockingbuffer).
Fluorescein-labeled p62, LC3, and ubiquitin (clone EX-9)
reactive antibodies were diluted to a concentration of 1 lg/
ml in blocking buffer and incubated for 1 h at room tem-
perature. Cells were then washed in PBS containing 0.1%
Tween-20 for 15 min. Next, the cells were stained with
Table 1 Testing compounds as modulators of autophagy and proteasome pathways: Hela, Jurkat and SK-N-SH cells were treated with the
highlighted compounds at the indicated concentrations and durations
Treatment Target Effect lM used Induction
time (h)
Cell line Aggresome
formation
Starvation Inhibits mammalian target of rapamycin (mTOR) Activates
autophagy
N/A 1–4 HeLa &
Jurkat
No
Rapamycin Inhibits mammalian target of rapamycin (mTOR) Activates
autophagy
0.2 6–18 HeLa &
Jurkat
No
PP242 ATP-competitive inhibitor of mTOR Activates
autophagy
1 18 Hela No
Lithium Inhibits IMPase and reduce inositol and IP3 levels;
mTOR-independent
Activates
autophagy
10,000 18 HeLa &
Jurkat
No
Trehalose Unknown, mTOR-independent Activates
autophagy
50,000 6 HeLa &
Jurkat
No
Baﬁlomycin A1 Inhibits vacuolar-ATPase Inhibits
autophagy
6–9 9 10
-3 18 HeLa &
Jurkat
Yes
Chloroquine Alkalinizes lysosomal pH Inhibits
autophagy
10–50 18 HeLa &
Jurkat
Yes
Tamoxifen Increases the intracellular level of ceramide and
abolishes the inhibitory effect of PI3K
Activates
autophagy
4–10 6–18 HeLa &
Jurkat
Yes
Verapamil Ca
2? channel blocker; reducesintracytosolic Ca
2?
levels; mTOR-independent
Activates
autophagy
40–100 18 HeLa &
Jurkat
Yes
Hydroxychloroquine Alkalinizes lysosomal pH Inhibits
autophagy
10 18 HeLa &
Jurkat
Yes
Loperamide Ca
2? channel blocker;reduces intra-cytosolic Ca
2?
levels; mTOR-independent
Activates
autophagy
5 18 HeLa No
Clonidine Imidazoline-1 receptor agonist; reduces cAMP
levels; mTOR-independent
Activates
autophagy
100 18 HeLa No
MG-132 Selective proteasome inhibitor Induce
aggresome
2–5 18 HeLa &
Jurkat
Yes
Epoxomicin Selective proteasome inhibitor Induce
aggresome
0.5 18 HeLa Yes
Lactacystin Selective proteasome inhibitor Induce
aggresome
4 Yes
Velcade
 Selective proteasome inhibitor Induce
aggresome
0.5 18 HeLa Yes
Amyloid beta
peptide 1–42
Induce oxidative stress Induce
aggresome
25 18 SK-N-SH Yes
Norclomipramine Alkalinizes lysosomal pH Inhibits
autophagy
5–20 18 HeLa Yes
Compounds that are listed as ‘‘Yes’’ under protein aggregation formation with ProteoStat
 dye were determined either by a signiﬁcant increase in
ﬂuorescence intensity in punctate cytoplasmic structures compared to control cells as observed by ﬂuorescence microscopy or as possessing an
APF value[25 determined as determined by ﬂow cytometry
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 dye (prepared according to kit instructions) for
30 min at room temperature and washed with PBS, covered
withglasscoverslip,sealedwithnailpolish,andobservedby
ﬂuorescence microscopy using a Texas Red ﬁlter set for the
ProteoStat
 dye, and an FITC ﬁlter set for ﬂuorescein-
labeled antibodies, respectively. All images were acquired
with a 639 objective lens (Carl Zeiss, Inc).
Staining of Tissue Sections
Parafﬁn-embedded tissue sections were deparafﬁnized
prior to staining. Brieﬂy, the microscope slide-mounted
specimen was immersed in a xylene substitute bath until
the parafﬁn was solubilized. The deparafﬁnized specimens
were then washed with a series of alcohol solutions of
decreasing alcohol concentration, to remove xylene, before
a ﬁnal wash with water. Then, the tissue sections were
ﬁxed with 4% formaldehyde in PBS for 15 min at 37C.
Following washing in deionized water, tissue sections were
stained with either 1 lM Thioﬂavin T in PBS or Proteo-
Stat
 dye (20009 in PBS from the ProteoStat
 Aggresome
Detection Kit) for 3 min, rinsing in water and destained in
1% acetic acid for 20 min. Finally, the tissue sections were
washed thoroughly in water, dehydrated, covered with
glass coverslips, mounted in anti-fade mounting medium,
and observed using ﬂuorescence microscope (Carl Zeiss,
Inc) using an FITC ﬁlter set for Thioﬂavin T and a Texas
Red ﬁlter set for ProteoStat
 dye, respectively. All images
were acquired with a 639 objective lens (Carl Zeiss, Inc).
For the antibody co-localization studies, tissue sections
were stained with ProteoStat
 dye as described above. The
tissue sections were then blocked in PBS containing 3%
bovine serum albumin (blocking buffer). Tau-reactive
monoclonal antibody (clone tau-13) and Alexa Fluor
 488
labeled beta amyloid reactive monoclonal antibody (clone
6E10) were diluted to a concentration of 2 lg/ml in
blocking buffer and incubated for 1 h at room temperature.
Tissues were then washed in PBS containing 0.1% Tween-
20 for 15 min. For tissues incubated with Tau-13 antibody,
the slides were subsequently incubated with Alexa Fluor

488 goat anti-mouse secondary antibody for 30 min at
room temperature. Finally, the tissue sections were washed
with PBS, covered with glass coverslips, mounted in anti-
fade mounting medium, and observed using a ﬂuorescence
microscope (Carl Zeiss, Inc) with a Texas Red ﬁlter set for
ProteoStat
 dye and FITC ﬁlter set for labeled antibodies,
respectively. All images were acquired with a 639 objec-
tive lens (Carl Zeiss, Inc).
Flow Cytometry
HeLa cells or Jurkat cells were grown to log phase, and
treated with 5 lM MG-132 or with vehicle for 16 h. At the
end of the treatment, adherent cells were trypsinized; while
Jurkat cells were simply collected by centrifugation
(4009g for 5 min). Samples were resuspended at 1 9 10
6
to 2 9 10
6 cells/ml. For each group, triplicate samples
were prepared. The cells were washed with PBS, ﬁxed in
4% formaldehyde in PBS for 30 min and then permeabi-
lized with 0.5% Triton X-100, 3 mM EDTA, pH 8 on ice,
for 30 min. The cells were then washed, and resuspended
in 500 ll ProteoStat
 dye (prepared according to kit
instructions). The samples were incubated for 30 min at
room temperature, protected from light. Experiments were
performed using a FACS Calibur benchtop ﬂow cytometer
(BD Biosciences, San Jose, CA) equipped with a blue
(488 nm) laser. ProteoStat
 dye ﬂuorescence was mea-
sured in the FL3 channel. No washing was required prior to
the ﬂow cytometric analysis.
For the immunocytochemistry study, after ﬁxing and
permeabilizing the cells, the cells were blocked in PBS
containing 3% bovine serum albumin for 1 h. Fluorescein-
labeled p62 antibody was diluted to a concentration of
2 lg/ml in blocking buffer and incubated with the cells for
1 h at room temperature. Cells were then washed in PBS
containing 0.1% Tween-20 for 15 min. Data were acquired
by FACS Calibur benchtop ﬂow cytometer (BD Biosci-
ences, San Jose, CA) equipped with a blue (488 nm) laser,
with the antibody signal measured in the FL1 channel.
Statistical Analysis
All of the experiments were performed at least three times.
Flow cytometry data were analyzed by comparison of
mean ﬂuorescence, through calculation of a term we refer
to as the Aggregation Propensity Factor (APF), as deﬁned
below.
APF = 100 9 ((MFItreated - MFIcontrol)/MFItreated),
wherein MFItreated and MFIcontrol are the mean ﬂuores-
cence intensity values from control and treated samples.
This metric is based upon a similar approach that is
commonly employed in the assessment of ﬂuorescent sig-
nal between control and treated groups in multidrug
resistance experiments, using a term referred to as Multi-
drug Resistance Activity Factor (MAF) [8]. APF is a
unitless term measured as the difference between the
amount of the ProteoStat
 dye accumulated within cells in
the presence and absence of a proteasome inhibitor or other
inducer of aggresome or inclusion body formation or pro-
tein aggregation. The ﬂuorescence measurement in the
presence of the proteasome inhibitor constitutes the maxi-
mal potential ﬂuorescence for the given cell population
when aggregated protein cargo has been generated. This
represents a standardization method, which eliminates
unknown cell type-speciﬁc variables that might inﬂuence
dye accumulation, such as cell size, shape, and volume,
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parison of test results and APF values.
Results
Monitoring Aggregated Protein Cargo with ProteoStat

Dye
In order to better understand the nature and contribution of
various autophagy pathway modulators to the speciﬁc tar-
geting of protein cargo for degradation, a novel ﬂuorescent
dye was developed that facilitates detection and quantiﬁ-
cation of aggregated protein cargo within aggresomes and
other inclusion bodies. A family of 130 molecular rotor
dyes was synthesized, each member of which was designed
to inherently decrease its non-radiative decay rate and
increase ﬂuorescence emission upon binding to the surface
of aggregated proteins. The ﬂuorescence properties of these
molecular rotor dyes were measured in the unbound
aqueous state and in the presence of a range of monomeric
and denatured ﬁbrillar proteins, including IgG, lysozyme,
pryuvate kinase, and trypsin. The lead dye from this screen
is referred to as the ProteoStat
 dye. The dye has an
absorption maximum of 500 nm and emission maximum of
600 nm. Relative to other dyes commonly employed for
the analysis of aggregated protein, ProteoStat
 dye pro-
vides a substantially higher ﬂuorescence intensity
enhancement in the presence of IgG aggregated protein
relative to monomeric IgG protein (Fig. 1). Similar results
were obtained for lysozyme, pryuvate kinase, and trypsin
(data not shown).
The ability of the novel dye to detect aggregated pro-
teins within ﬁxed and permeabilized cells was next eval-
uated. MG-132, a relatively non-speciﬁc proteasome
inhibitor, has also been shown to perturb protein homeo-
stasis, inducing both the unfolded protein response (UPR)
and the heat shock response (HSR) [9, 10]. MG-132 is
known to accelerate the formation of perinuclear aggre-
somes as well as inclusion bodies within cells [6]. After
treating cells with MG-132, ProteoStat
 dye was found to
readily highlight aggregated protein cargo accumulating
within vacuolar cytoplasmic structures, as observed by
ﬂuorescence microscopy (Fig. 2). Examination of the dis-
tribution of the ﬂuorescent dye within cells treated with
MG-132, revealed a punctate pattern of cytoplasmic
staining, as well as staining of certain inclusion bodies
within or immediately adjacent to the nucleus itself. Mul-
tiple cytoplasmic inclusion bodies were readily discerned
using the ﬂuorescent dye. It should be noted that true
aggresomes are characterized by a single large protein
aggregate in cells that colocalizes with the centrosome in a
microtubule-dependent fashion. The formation of the
multiplicity of inclusion bodies we observed upon MG-132
treatment was not sensitive to the histone deacetylase 6
inhibitor, N-hydroxy-7-[5-(4-tertbutoxycarbonylaminophenyl)-
3-isoxazolecarboxamido]heptamide (BML-281) [11]o r
nocodazole (data not shown). This suggests that the gen-
erated inclusion bodies do not meet the strictest deﬁnition
for aggresomes. The described probe appears to detect
aggregated protein cargo within a variety of inclusion
bodies, regardless of whether they are co-localized with
the centrosome or formed in a microtubule-dependent
manner.
The ability to detect aggresomes and related inclusion
bodies was further demonstrated using various potent, cell
permeable, and selective proteasome inhibitors: lactacy-
stin, epoxomicin and bortezomib (Velcade
), as shown in
Fig. 3. Previous studies have shown that bortezomib-
mediated proteasomal inhibition results in the accumula-
tion of large quantities of ubiquitin-conjugated proteins
organized into perinuclear structures termed ‘‘aggresomes’’
[12]. All of the tested proteasome inhibitors induced the
accumulation of cytoplasmic inclusion bodies within the
cells, as demonstrated with the ProteoStat
 dye. Efforts to
stain inclusion bodies in living cells were not met with
success, however. Instead of discrete punctuate staining of
aggregated cargo, a weak, diffuse cytoplasmic staining was
observed that differed little between control cells and cells
treated with a proteasome inhibitor. This could possibly be
Fig. 2 Protein aggregation
detected by ProteoStat
 dye as
observed by ﬂuorescence
microscopy: Hela cells were
mock-induced with 0.2%
DMSO (a) or induced with
5 lM MG-132 (b) for 16 h at
37C. After treatment, cells
were incubated with
ProteoStat
 dye for 30 min.
Nuclei were counter-stained
with Hoechst 33342 in the
images
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bound vacuolar structures within the cells.
A range of conditions, including treatment with various
small molecule modulators of autophagy, were next eval-
uated using the cell-based protein aggregation assay
(Table 1). Numerous small molecule compounds known to
inhibit the autophagy pathway, leading to the accumulation
of autophagosomes and autophagolysosomes, were also
found to lead to protein cargo accumulating within vacu-
olar cytoplasmic structures, as observed by ﬂuorescence
microscopy. Aside from the proteasome inhibitors,
Baﬁlomycin A, a potent and speciﬁc inhibitor of vacuolar
H ? ATPase, as well as certain cationic amphiphilic drugs
(chloroquine, hydroxychloroquine, and norclomipramine),
known to disrupt lysosomal function, also led to the
accumulation of these cytoplasmic aggregates. Interest-
ingly, two other cationic drugs, loperamide and clonidine,
did not trigger an accumulation of aggregated proteins
within the cells.
Co-localization of Aggregated Protein
with Ubiquitinylation and Various Pathway Proteins
Implicated in Autophagy
Co-localization of ﬂuorescently labeled ubiquitin antibody
conjugate with ProteoStat
 dye is shown in Fig. 4a, high-
lighting interactions between aggregated protein cargo and
ubiquitinylation status. The ubiquitin signal is observed to
be colocalized exclusively with the aggregated protein
cargo, but it should be remembered that cells were ﬁxed and
permeabilized, which likely removed any free ubiquitin and
ubiquitinylated substrates present in the cytosol. Figure 4b
demonstrates that a ﬂuorescein-conjugated antibody direc-
ted toward p62 (a ubiquitin-binding scaffold protein that
co-localizes with ubiquitinylated protein aggregates) also
co-localizes with the ProteoStat
 dye within cells treated
with MG-132. Furthermore, co-localization between ﬂuo-
rescein-labeled antibodies reactive with LC3 (a ubiquitin-
like autophagy cascade protein residing in the phagophore
membrane) and aggregated protein cargo was demon-
strated, as shown in Fig. 4c. The described co-localization
studies demonstrate the capability of the ProteoStat
 dye to
be used to analyze the interactions between aggregated
protein cargo, protein post-translational modiﬁcations, and
various autophagy pathway proteins. The long wavelength
red emission of the ﬂuorescent probe is especially suitable
for studies using green ﬂuorescent dye conjugates, such
as ﬂuorescein, Alexa Fluor
 488, Oregon Green
 488,
BODIPY
-FL, HiLyte Fluor
TM 488, and DyLight
 488.
Cell Culture-Based Model Mimicking Elements
of Alzheimer’s Disease Pathology
Next, we attempted to establish a cell culture-based assay
mimicking the accumulation of b-amyloid, as observed in
Alzheimer’s disease. Figure 5b shows ProteoStat
 dye is
able to detect amyloid ﬁbrils within an SK-N-SH human
neuroblastoma cell line induced to form inclusion bodies
by overnight incubation with exogenously added amyloid
beta 1–42 peptide. Furthermore, SMER28, a small
Fig. 3 Effect of various potent,
cell permeable and selective
proteasome inhibitors on protein
aggregation in Hela cells, as
observed by ﬂuorescence
microscopy a control, b 0.5 lM
epoxomicin, c 4 lM lactacystin,
and d 0.5 lM Velcade
 with
16 h incubation
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to its effect on b-amyloid peptide accumulation within the
cells. SMER28 has previously been shown to act via an
mTOR-independent mechanism to increase autophago-
some synthesis and enhance the clearance of model
autophagy substrates, such as [A53T]a-synuclein and
mutant huntingtin fragments [13, 14]. It has also been
demonstrated that SMER28 attenuates mutant huntingtin-
fragment toxicity in Drosophila models, suggesting thera-
peutic potential. As shown in Figs. 5c and d, SMER28 was
able to substantially reduce accumulation of b-amyloid
peptide in SK-N-SH human neuroblastoma cells, suggest-
ing this assay could potentially enable screening of
aggregation inhibitors relevant to neurodegenerative dis-
ease, in an authentic cellular context.
Detecting Protein Aggregates in Post-Mortem Brain
Tissue Sections from Patients with Alzheimer’s Disease
Thioﬂavin T (ThT) is a widely employed histological probe
for detecting the formation of amyloid ﬁbrils in brain tissue
[15]. However, this dye is not an ideal predictor of the degree
of ﬁbrillization because its ﬂuorescence varies substantially
depending upon the structure and morphology ofthe amyloid
ﬁbrils.Wefoundthatthedyegeneratesfairlyhighbackground
and weak ﬂuorescent signal in brain tissue sections, as shown
in Fig. 6a. Thus, optimized protocols for the detection of
amyloid plaques in frozen and parafﬁn-embedded tissue sec-
tions of human brain were developed using the Proteostat

dye. Relative to ThT, this novel probe demonstrates signiﬁ-
cantlyhigherﬂuorescenceemissionintensityenhancementin
Fig. 4 Co-localization studies with ﬂuorescently labeled antibodies,
as observed by ﬂuorescence microscopy. HeLa cells were treated for
12 h with 5 lM MG-132. Panel A Protein aggregation detected by
ProteoStat
 dye co-localizes with ubiquitin. a ProteoStat
 dye
stained, b cells treated with ﬂuorescein-labeled ubiquitin-reactive
antibody (clone EX-9) and c composite image. Panel B Protein
aggregation detected by ProteoStat
 dye co-localizes with
ﬂuorescein-labeled p62-reactive antibody. a ProteoStat
 dye stained
cells, b cells treated with ﬂuorescein-labeled p62-reactive antibody,
c composite image. Panel C Protein aggregation detected by
ProteoStat
 dye co-localizes with LC3. a ProteoStat
 dye stained,
b cells treated with ﬂuorescein-labeled LC3-reactive antibody and
c composite image
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background (shown in Fig. 6b). Inaddition, use of antibodies
directed against b-amyloid and tau protein, in conjunction
with the ProteoStat
 dye, conﬁrm the selectivity of the probe
for detection of amyloid plaques in post-mortem brain tissue
of patients with Alzheimer’s disease (Fig. 7a, b).
Fig. 5 Treatment of SK-N-SH
cells with amyloid beta peptide
1–42 induces aggregate
formation, while SMER28
blocks this accumulation, as
demonstrated by ﬂuorescence
microscopy. a Untreated cells,
b 25 lM amyloid beta peptide,
c 25 lM amyloid beta peptide
with 5 lM SMER28, d 25 lM
amyloid beta peptide with
50 lM SMER28
Fig. 6 Detection of amyloid
plaques within parafﬁn-
embedded tissue sections of
human brain tissue (cerebellum)
from patients with Alzheimer’s
disease and human adult normal
brain tissue (cerebellum) with
a Thioﬂavin T dye,
b ProteoStat
 dye, as observed
by ﬂuorescence microscopy
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the Accumulation of Protein Aggregates Within Cells
A novel ﬂow cytometry cell-based assay was next devel-
oped using the ProteoStat
 dye. Figure 8a demonstrates
typical results of ﬂow cytometry-based analysis of cell
populations using the ProteoStat
 dye. Uninduced control
and 5 lM MG-132-treated Jurkat cells were employed in
the investigation. After 16 h treatment, ﬁxed and perme-
abilized cells were stained with the ProteoStat
 dye and
then analyzed without washing by ﬂow cytometry. Results
are presented using histogram overlay graphs. Control cells
displayed minimal ﬂuorescence staining with the dye. The
ProteoStat
 dye signal increased about three-fold in the
MG-132 treated cells, readily demonstrating that MG-132
induced protein aggregate formation in Jurkat cells. An
APF value of approximately 72, as deﬁned in ‘‘Materials
and Methods’’ section, demonstrates that the control and
treated cell populations were readily distinguishable by
ﬂow cytometry. For comparison, routinely an MAF cut-off
value of about 20–25 is employed in ﬂow cytometry assays
of multi-drug resistance [8]. Protein aggregate accumula-
tion in the Jurkat cells was conﬁrmed by ﬂow cytometry
analysis using ﬂuorescein-conjugated p62-reactive anti-
body (Fig. 8b). Thus, the described assay allows, for the
ﬁrst time, easy quantiﬁcation of aggresome accumulation
by ﬂow cytometry. The advantage of the dye-based
approach relative to the antibody one is that staining and
analysis are much more rapid. Simultaneous staining with
the ﬂuorescein-conjugated antibody and the red ﬂuorescent
dye was also feasible (data not shown).
Discussion
Our overall objective was to develop an improved ﬂuo-
rescent probe for the analysis of aggregated protein cargo
within cells and tissues. The benzothiazole dye, Thioﬂavin
T (ThT), has routinely been employed for the determina-
tion of aggregated protein deposits, both ex vivo and in
vitro. In the presence of amyloid ﬁbrils, ThT displays a
strong increase in ﬂuorescence intensity, with excitation
and emission maxima of roughly 440 and 490 nm,
respectively, depending on buffer composition. The
intercalation of ThT molecules into grooves between
solvent-exposed side chains within the characteristic
crossed-b-sheet structure of the amyloid ﬁbril appears to
lead to the increased ﬂuorescence signal [16]. ThT is a
molecular rotor dye and it is thought that the dramatic
increase in quantum yield upon binding to aggregated
proteins arises from inhibition of the free rotation of its
constituent aromatic rings. Conversely, in aqueous solution
Fig. 7 Co-localization studies from amyloid plaques within parafﬁn-
embedded tissue sections of human brain tissue (cerebellum) from
patients with Alzheimer’s disease with ﬂuorescently-labeled antibod-
ies, as observed by ﬂuorescence microscopy. Panel A ProteoStat
 dye
co-localizes with Tau protein. a Tau-reactive antibody (clone Tau-13)
which recognizes human tau and speciﬁcally stains brain tissue early
in Alzheimer’s disease, b ProteoStat
 dye stained tissue, c composite
image. Panel B ProteoStat
 dye co-localizes with beta amyloid.
a beta amyloid reactive antibody (clone 6E10) which speciﬁcally
binds b-amyloid aggregates, b ProteoStat
 dye stained tissue,
c composite image
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123when molecular rotation is not constrained, excited ThT
molecules apparently undergo a torsional relaxation which
effectively competes with the radiative transition, render-
ing the molecule essentially non-ﬂuorescent.
The strong absorptive and ﬂuorescent properties of
certain phenolic aromatic small molecules, such as quer-
cetin and curcumin, have been shown to signiﬁcantly bias
ThT-based ﬂuorescence measurements [17]. For example,
the presence of 10 nM curcumin is sufﬁcient to interfere
substantially with ﬂuorescence signal generation associated
with ThT binding to ﬁbrillar b-amyloid (1–42). This can be
problematic when ThT-based ﬂuorescence assays are
employed for studies where the impact of polyphenolic
compounds on protein ﬁbrillation is being monitored, such
as in small molecule compound screening projects
designed to identify anti-amyloid drug candidates. Indeed,
intrinsic tissue ﬂuorescent properties of various cellular
constituents, such as ﬂavins, reduced NAD(P)H, collagen,
and elastin also substantially overlap with the absorption
and ﬂuorescence emission wavelengths of ThT [18].
Additionally, aldehyde ﬁxatives are known to form cova-
lent bonds between adjacent amine-containing groups
through Schiff acid–base reactions to generate autoﬂuo-
rescent background with similar spectral properties to those
of ThT [18].
A ﬂuorescent derivative of Congo Red, (trans, trans)-1-
bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene
(BSB), has also been employed for the detection of
amyloid deposits in tissue sections [19]. With an emission
maximum of 520 nm, this probe offers improved perfor-
mance with respect to the avoidance of background asso-
ciated with intrinsic and ﬁxative-induced autoﬂuorescence
in cells and tissues. However, the probe’s absorption
maximum of 340 nm requires an ultraviolet laser source
for optimal excitation, restricting its widespread adoption
on various instrument platforms.
The ProteoStat
 dye was developed to overcome the
inherent limitations of commonly employed molecular
probes for the assessment of protein aggregates in cells and
tissues. Like ThT and BSB, the ProteoStat
 dye is a
molecular rotor that binds selectively to aggregated pro-
tein. The dye’s red ﬂuorescence emission maximum of
600 nm minimizes background problems associated with
intrinsic or ﬁxative-induced auto-ﬂuorescence. Since
Fig. 8 Identifying protein
aggregation by ﬂow cytometry:
Jurkat cells were mock-induced
with 0.2% DMSO or induced
with 5 lM MG-132 for 16 h at
37C. After treatment, cells
were ﬁxed and incubated with
a ProteoStat
 dye, or
b ﬂuorescein-labeled p62-
reactive antibody. Then, the
samples were analyzed by ﬂow
cytometry. Results are presented
as histogram overlays. In
MG-132 treated cells,
ProteoStat
 dye red
ﬂuorescence signal increases
about 3-fold (shown in panel A)
while the ﬂuorescein signal
increases about 2.5-fold (shown
in panel B)
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123detection of aggregated protein cargo with the ProteoStat

dye is based upon obtaining ﬂuorescent signal at longer
wavelengths than used for ThT and BSB dyes, it potentially
enables the quantiﬁcation of amyloid ﬁbrils in the presence
of colored and ﬂuorescent compounds that interfere with
ﬂuorescence signal generated by these other dyes. Figure 6
highlights the substantial reduction in background noise
afforded by the ProteoStat
 dye relative to ThT.
The ProteoStat
 dye’s absorbance maximum of 500 nm
enables its implementation on a wide variety of instrument
platforms, including any ﬂow cytometer equipped with a
488 nm argon ion laser. Relative to ThT and BSB, the
ProteoStat
 dye’s absorbance maximum is well aligned
with the emission of a standard argon ion laser source. As
described herein, we were able to detect aggregated protein
cargo within aggresomes and related inclusion bodies
effectively in both ﬁxed and permeabilized cells by ﬂow
cytometry (Fig. 8). The APF value was calculated from the
absolute ﬂuorescence obtained in the absence and presence
of MG-132, using the equation provided in ‘‘Materials
and Methods’’ section. A readily measurable difference
between control and MG-132 treated cells was clearly
demonstrated, indicating that the described ﬂow cytometry
assay provides a reliable quantitative measure of aggre-
gated protein cargo accumulation within cells. To our
knowledge, we present the ﬁrst dye-based ﬂow cytometry
approach to quantiﬁcation of aggregated protein in aggre-
somes and related inclusion bodies residing within cells.
Analternativeapproachtodetectaggregatedproteincargo
within cells relies upon genetically encoded live-cell ﬂuo-
rescent biosensors. Typically, an inclusion body-forming
protein fused to green ﬂuorescent protein (GFP) is over-
expressed in a cell line in order to monitor the protein
aggregationprocess[20,21].TheadoptionofGFPtechnology
to over-express fusions of aggregation-prone proteins has
allowed study of the aggregation phenomenon in living cells.
Although these genetically encoded aggregation sensors
provide a means of identifying aggresomes and related
inclusion bodies, none report directly on the levels and
activities of endogenous proteins and peptides themselves.
One potential limitation to the implementation of GFP fusion
proteins in this context is the real possibility of steric hin-
drance at the N- or C-terminus of the aggregation-prone pro-
tein,interferingwiththeorderedself-associationprocess.This
is particularly of concern with respect to studies involving
aggregation-prone peptides. For instance, GFP (238 amino
acids) is roughly six times larger than b-amyloid peptides
(39–43 amino acids), the principal components of amyloid
plaques found in the brains of Alzheimer’s disease patients.
While the ProteoStat
 dye can not currently be employed to
stain living cells, it is suitable for staining ﬁxed and perme-
abilizedones,allowingco-localizationstudieswithantibodies
to various other proteins of interest.
There is a growing body of evidence that neurodegen-
erative diseases, such as Alzheimer’s disease, Parkinson’s
disease, and Huntington’s disease encompass common
cellular and molecular mechanisms involving protein
aggregation and inclusion body formation [22]. The
aggregates usually consist of ﬁbers containing misfolded
protein with a beta-sheet conformation, termed amyloid.
Usually, these deposits contain ubiquitinylated protein
conjugates, suggesting a failure in the clearance of proteins
targeted for proteasomal degradation. The ubiquitin–pro-
teasome system (UPS) is thought to be limited in its
capacity to degrade aggregated proteins. Instead, their
removal is believed to be primarily mediated by autophagy,
a system by which cells sequester cytosolic cargo for
delivery to lysosomes. The UPS and autophagy pathways
were once considered separate systems but it now appears
there is cross-talk and cooperation between them, with
ubiquitin modiﬁcation acting as a signalling molecule in
both cases. The p62 protein (also called sequestosome 1
(SQSTM1)) is an ubiquitin-binding scaffold protein that
co-localizes with ubiquitinylated protein aggregates in, for
example, many neurodegenerative diseases and protein-
opathies of the liver. In addition to its putative role in the
targeting of ubiquitinylated cargo for proteasomal degra-
dation, p62 binds both target-associated ubiquitin and LC3
(an ubiquitin-like autophagy cascade protein) conjugated to
the phagophore membrane, thereby effectively serving as
an autophagic receptor for ubiquitinylated targets [23].
Aggresomes, inclusion bodies that form when the ubiqui-
tin–proteasome machinery is overwhelmed with aggre-
gated proteins, may serve as storage depots for cargo
awaiting degradation by autophagy. Using the ProteoStat

dye, we were able to conﬁrm colocalization of aggregated
protein cargo, ubiquitin, p62, and LC3.
Current methods for identifying potential ﬁbrillization
inhibitors are primarily based upon ﬁrst screening com-
pounds biochemically using puriﬁed protein (tau) or pep-
tide (b-amyloid), followed by testing in animals [24].
However, different biochemical assays have been found to
generate different compound leads. In addition, since the
biochemical assays are based upon using a single peptide
or protein to measure self-association, no aggregation
pathway modulators can be identiﬁed by the approach.
Most compounds that inhibit b-amyloid or tau aggregation
in these biochemical assays have subsequently failed to
demonstrate effectiveness in animal studies. Methods
based upon monitoring the aggregation state of a pure
protein or peptide fail to recapitulate any cellular regula-
tory pathways that might inﬂuence protein aggregation
state or accumulation. The described dye-based assay
allowed assessment of the role of SMER28, an activator of
autophagy, on the accumulation of b-amyloid within neu-
roblastoma cells, highlighting the potential utility of this
184 Cell Biochem Biophys (2011) 60:173–185
123basic approach to the identiﬁcation of small molecule
regulators that do not directly interfere with the aggrega-
tion of the target protein or peptide. The described
approach could ﬁnd application in the identiﬁcation of
activators of autophagy that might facilitate clearance of
aggregated protein cargo from cells and tissues.
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